Press Releases
Search by Year
-
20 May 2006
First Quarter 2006 Sales: Up 7.8% At Constant Exchange Rates
Marcy l'Etoile, France - April 20, 2006. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its sales for the first three months of 2006. Sales amounted to €255.6 millio...
-
25 Apr 2006
bioMérieux NucliSENS® easyMAG™ Receives Technology Innovation of the Year Award from Frost & Sullivan
Durham, NC, USA - April 25, 2006. 2006 Technology Innovation Award of the Year in the field of In Vitro Diagnostics. bioMérieux has been the proud recipient of 2006 Technology Innovation of the Year a...
-
10 Apr 2006
bioMérieux launches a proactive solution for Listeria risk control with VIDAS® LDUO
Marcy l'Etoile, France - April 10, 2006. bioMérieux offers food-processing industries the world’s first proactive solution for Listeria risk control with VIDAS® LDUO. VIDAS® LDUO innovation bioMérieux...
-
29 Mar 2006
ExonHit and bioMérieux reach an important research milestone in the molecular detection of breast cancer from blood samples
Marcy l'etoile and Paris, France - 03/29/2006. ExonHit Therapeutics, a French drug and diagnostic discovery company, and bioMérieux, a major player in the field of in vitro diagnostics, announce today...
-
20 Mar 2006
bioMérieux announces its results for 2005
Marcy l'Etoile, France - March 20, 2006. • Operating income up 7.3% • Net income up 13%...
-
02 Feb 2006
bioMérieux launches an avian flu test for research purposes
Marcy l'étoile, France - 02/02/2006. As a major player in the field of in vitro diagnostics, bioMérieux confirms its commitment to the fight against emerging diseases and launches its avian flu detect...
-
19 Jan 2006
2005 Sales Up 5.7% at Constant Exchange Rates
Marcy l'Etoile, France - January 19, 2006. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its 2005 sales.
-
28 Nov 2005
E. coli O157: bioMérieux offers food processing industries fast, reliable detection, using VIDAS® ECO and VIDAS ICE tests
Marcy l'Etoile, France - November 28, 2005. E.coli O157 represents a major risk for consumers. It is the main cause of hemolytic uremic syndrome (HUS) that leads to acute renal failure in children. Th...
-
20 Oct 2005
Nine-Month Sales Up 5%
Marcy l'Etoile, France - October 20, 2005. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its nine-month 2005 sales.
-
13 Oct 2005
bioMérieux and ExonHit Therapeutics Extend their Strategic Collaboration
Marcy l'Etoile and Paris, France - October 13, 2005. bioMérieux and ExonHit announced today that they signed an agreement to extend their collaboration for six years for the discovery and development ...